Current Drug Targets

Author(s): Nadish Garg and William P. Fay

DOI: 10.2174/138945007781662355

Plasminogen Activator Inhibitor-1 and Restenosis

Page: [1003 - 1006] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.

Keywords: Urokinase, vascular wall, restenosis, carotid artery ligation, VSMC proliferation